PT  - JOURNAL ARTICLE
AU  - Bessie Stamm
AU  - Medha Barbhaiya
AU  - Caroline Siegel
AU  - Sarah Lieber
AU  - Michael Lockshin
AU  - Lisa Sammaritano
TI  - Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology
AID  - 10.1136/lupus-2022-000840
DP  - 2022 Dec 01
TA  - Lupus Science & Medicine
PG  - e000840
VI  - 9
IP  - 1
4099  - http://lupus.bmj.com/content/9/1/e000840.short
4100  - http://lupus.bmj.com/content/9/1/e000840.full
SO  - Lupus Sci Med2022 Dec 01; 9
AB  - Fertility is often a concern for women with SLE. In addition to known indirect factors that influence the ability of a woman with SLE to become pregnant, such as cytotoxic agents, other medications, advanced age and psychosocial effects of the disease, direct disease-related factors are believed to influence fertility. These include diminished ovarian reserve, menstrual irregularities (a function of disease activity) and the presence of antiphospholipid antibodies. The question of whether SLE intrinsically affects fertility, however, remains unanswered. In this review, we address known factors affecting fertility, assess current data regarding a direct impact of SLE on fertility and evaluate potential disease-related risk factors. We focus primarily on studies measuring anti-Müllerian hormone and antral follicle count, the most widely measured markers of ovarian reserve. Our goal is to provide information to rheumatologists faced with counselling patients with SLE regarding their fertility, family planning and options for assisted reproductive technologies, which now include fertility preservation through oocyte cryopreservation.